The authors have already reported an effect of a novel antiangiogenic therapy (ABT-510 nonapeptide), antiangiogenic peptide mimetic of TSP-1, on vascular inflammation and atherosclerosis [13]. The gene discussed is THBS1; the disease is atherosclerosis.